HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characteristics of sebaceous carcinoma and early outcomes of treatment using Mohs micrographic surgery versus wide local excision: an update of the Mayo Clinic experience over the past 2 decades.

AbstractBACKGROUND:
Sebaceous carcinoma (SC) is a rare cutaneous neoplasm.
OBJECTIVE:
To characterize SC and treatment approaches and outcomes.
METHODS AND MATERIALS:
We retrospectively reviewed records of patients with SC from 1992 through 2012. Recurrence-free survival was estimated and compared between groups.
RESULTS:
We identified 52 patients with SC (39, 75.0% male). Mean age ± standard deviation at diagnosis was 72.7 ± 10.8. Forty-nine patients (94.2%) were white. Twenty-one (of 29 with known status) had a diagnosis of Muir-Torre syndrome. Six had multiple primary SCs (total of 73 SCs in 52 patients). The most common locations for SC were the back (20.5%), cheek (13.7%), nose (11.0%), and eye (9.6%). Treatment was recorded for 70 SCs; 35 (50.0%) were treated using Mohs micrographic surgery (MMS) and 26 (37.1%) using wide local excision (WLE). Of the 45 patients (66 SCs) with clinical follow-up, three (6.7% of patients; 4.8% of SCs) had documented recurrence.
CONCLUSION:
MMS and WLE are effective treatments for SC. Further research is warranted to determine whether one treatment is more efficacious than the other.
AuthorsJennifer L Hou, Jill M Killian, Christian L Baum, Clark C Otley, Randall K Roenigk, Christopher J Arpey, Amy L Weaver, Jerry D Brewer
JournalDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (Dermatol Surg) Vol. 40 Issue 3 Pg. 241-6 (Mar 2014) ISSN: 1524-4725 [Electronic] United States
PMID24460730 (Publication Type: Journal Article)
Copyright© 2014 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.
Topics
  • Adenocarcinoma, Sebaceous (pathology, surgery)
  • Aged
  • Disease-Free Survival
  • Female
  • Humans
  • Male
  • Mohs Surgery
  • Retrospective Studies
  • Skin Neoplasms (pathology, surgery)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: